PARSIPPANY, N.J. — Watson is challenging the patent protection on two eye drugs made by Allergan, the generic drug maker said Tuesday. Watson announced that it had filed with the Food and Drug ...

DUBLIN--(BUSINESS WIRE)--The "Lumigan RC - Drug Insight, 2019" report has been added to ResearchAndMarkets.com's offering. Lumigan RC Drug Insight, 2019 highlights the drug marketed details and the ...

Alembic Pharmaceuticals is introducing its first ophthalmic glaucoma product. The company has launched its generic Lumigan (bimatoprost ophthalmic solution 0.03%). The drug is indicated for the ...

On January 29, 2021, the Alberta Court of Appeal dismissed Allergan’s appeal of a judicial review decision relating to the interchangeability of its glaucoma drug, LUMIGAN RC (0.01% bimatoprost), with ...

The full CMI on the next page has more details. If you are worried about using this medicine, speak to your doctor or pharmacist. LUMIGAN® PF eye drops contains the active ingredient bimatoprost.

Please provide your email address to receive an email when new articles are posted on . The preservative-free gel was noninferior to a solution with benzalkonium chloride at all time points for 12 ...